New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
08:37 EDTCASICASI Pharmaceuticals expect stable environment going into 2H14
Sees quarterly operating expenses of $65M-$67M in 2H14. Expects initial contributions and modest sequential sales growth from 2H14 initiatives.
News For CASI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
17:10 EDTCASISpectrum reports 16.66% stake in CASI Pharmaceuticals
Spectrum entered into the investment agreements in order to acquire shares of common stock of CASI Pharmaceuticals for investment purposes with the goal of increasing the value of the company as a result of, among other things, CASI's development and commercialization of Zevalin and captisol-enabled melphalan in Greater China.
September 18, 2014
07:07 EDTCASISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information
07:05 EDTCASISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use